PREPARATION AND UTILITY OF SUBSTITUTED QUINAZOLINE COMPOUNDS WITH ALPHA-ADRENERGIC BLOCKING EFFECTS
申请人:GANT Thomas G.
公开号:US20080039473A1
公开(公告)日:2008-02-14
The present disclosure is directed to modulators of alpha-adrenergic receptors and pharmaceutically acceptable salts and prodrugs thereof, the chemical synthesis thereof, and the use of such compounds for the treatment and/or management of hypertension, cardiac failure, prostatitis, and benign prostatic hyperplasia, and any other condition in which it is beneficial to modulate an alpha-adrenergic receptor.
本公开涉及α-肾上腺素受体的调节剂及其药用盐和前药,其化学合成,以及利用这些化合物治疗和/或管理高血压、心力衰竭、前列腺炎和良性前列腺增生,以及任何其他需要调节α-肾上腺素受体的情况。